Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

NCT01109004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

758

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: lenalidomide, bortezomib and dexamethasone
DRUG: Lenalidomide

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]
[object Object]